During the NAFLD induction phase (first 2 weeks) rats in groups A, B, C, D, and E received HFD and were intraperitoneally (IP) injected with DXM 1 mg/kg once daily to induce NAFLD (dexamethasone 8mg/2 ml Amp, Amriya for Pharmaceutical Industries Alexandria, Egypt), which was diluted with water for injection (El-Nasr Pharmaceutical Chemicals Company, Abou-Zaabal, Egypt)
Nasser J, Hosseini A, Barlow G, et al
( A ) Expression level of INS (red), GCG (green), and SST (blue) projected on the UMAP generated from human islets treated with saline (CTRL) or liraglutide (LIRA)
As of June 2026, the FDA is in a public comment period on a proposal to formally exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulk Drug Substances List
LEWES, Del., July 15, 2026 (Newswire.com) - Quick disclosure before you read further: This is a paid advertorial